Andritsos, L., and H. Khoury. 2002. Chronic lymphocytic leukemia. Curr. Treat. Options Oncol. 3:225-231.
Asquith, B., C. Debacq, D. Macallan, L. Willems, and C. Bangham. 2002. Lymphocyte kinetics: the interpretation of labelling data. Trends Immunol. 23:596-601.
Blaise, R., P. Masdehors, A. Lauge, D. Stoppa-Lyonnet, C. Alapetite, H. Merle-Beral, J. L. Binet, S. Omura, H. Magdelenat, L. Sabatier, and J. Delic. 2001. Chromosomal DNA and p53 stability, ubiquitin system and apoptosis in B-chronic lymphocytic leukemia lymphocytes. Leuk. Lymphoma 42:1173-1180.
Burny, A., F. Bex, H. Chantrenne, Y. Cleuter, D. Dekegel, J. Ghysdael, R. Kettmann, M. Leclercq, J. Leunen, M. Mammerickx, and D. Portetelle. 1978. Bovine leukemia virus involvement in enzootic bovine leukosis. Adv. Cancer Res. 28:251-311.
Caligaris-Cappio, F. 2000. Biology of chronic lymphocytic leukemia. Rev. Clin. Exp. Hematol. 4:5-21.
Copeland, K. F., and J. L. Heeney. 1996. T helper cell activation and human retroviral pathogenesis. Microbiol. Rev. 60:722-742.
Corley, R. B., F. E. Lund, T. D. Randall, L. B. King, S. Doerre, and D. L. Woodland. 1992. Mouse mammary tumor proviral gene expression in cells of the B lineage. Semin. Immunol. 4:287-296.
Dameshek, W. 1967. Chronic lymphocytic leukemia - an accumulative disease of immunologically incompetent lymphocytes. Blood Suppl. 29:82-84.
Debacq, C., B. Asquith, P. Kerkhofs, D. Portetelle, A. Burny, R. Kettmann, and L. Willems. 2002. Increased cell proliferation, but not reduced cell death, induces lymphocytosis in bovine leukemia virus-infected sheep. Proc. Natl. Acad. Sci. USA 99:10048-10053.
Dequiedt, F., G. H. Cantor, V. T. Hamilton, S. M. Pritchard, W. C. Davis, P. Kerkhofs, A. Burny, R. Kettmann, and L. Willems. 1999. Bovine leukemia virus-induced persistent lymphocytosis in cattle does not correlate with increased ex vivo survival of B lymphocytes. J. Virol. 73:1127-1137.
Dequiedt, F., E. Hanon, P. Kerkhofs, P. P. Pastoret, D. Portetelle, A. Burny, R. Kettmann, and L. Willems. 1997. Both wild-type and strongly attenuated bovine leukemia viruses protect peripheral blood mononuclear cells from apoptosis. J. Virol. 71:630-639.
Dequiedt, F., R. Kettmann, A. Burny, and L. Willems. 1995. Mutations in the p53 tumor-suppressor gene are frequently associated with bovine leukemia virus-induced leukemogenesis in cattle but not in sheep. Virology 209:676-683.
Egerer, G., M. Hensel, and A. D. Ho. 2001. Infectious complications in chronic lymphoid malignancy. Curr. Treat. Options Oncol. 2:237-244.
Faderl, S., M. J. Keating, K. A. Do, S. Y. Liang, H. M. Kantarjian, S. O'Brien, G. Garcia-Manero, T. Manshouri, and M. Albitar. 2002. Expression profile of 11 proteins and their prognostic significance in patients with chronic lymphocytic leukemia (chronic lymphocytic leukemia). Leukemia 16:1045-1052.
Ferrer, J. F., R. R. Marshak, D. A. Abt, and S. J. Kenyon. 1979. Relationship between lymphosarcoma and persistent lymphocytosis in cattle: a review. J. Am. Vet. Med. Assoc. 175:705-708.
Gentile, G., M. Cipone, C. Tassi, S. Pileri, and P. Tazzari. 1992. Ki-67 antigen expression in lymphocytes of cattle infected with bovine leukemia virus (BLV). Dtsch. Tierarztl. Wochenschr. 99:206-208.
Hamblin, T. 2002. Chronic lymphocytic leukaemia: one disease or two? Ann. Hematol. 81:299-303.
Hanon, E., J. C. Stinchcombe, M. Saito, B. E. Asquith, G. P. Taylor, Y. Tanaka, J. N. Weber, G. M. Griffiths, and C. R. Bangham. 2000. Fratricide among CD8(and) T lymphocytes naturally infected with human T cell lymphotropic virus type I. Immunity 13:657-664.
Hjalmar, V., R. Hast, and E. Kimby. 2002. Cell surface expression of CD25, CD54, and CD95. Eur. J. Haematol. 68:127-134.
Hubmann, R., J. D. Schwarzmeier, M. Shehata, M. Hilgarth, M. Duechler, M. Dettke, and R. Berger. 2002. Notch2 is involved in the overexpression of CD23 in B-cell chronic lymphocytic leukemia. Blood 99:3742-3747.
Jacobson, S. 2002. Immunopathogenesis of human T cell lymphotropic virus type I-associated neurologic disease. J. Infect. Dis. 186(Suppl. 2):S187-S192.
Kagi, D., B. Ledermann, K. Burki, R. M. Zinkernagel, and H. Hengartner. 1996. Molecular mechanisms of lymphocyte-mediated cytotoxicity and their role in immunological protection and pathogenesis in vivo. Annu. Rev. Immunol. 14:207-232.
Kalvelyte, A. V., and L. C. Pabrezaite. 1998. Proto-oncogene expression in bovine peripheral blood leukemic lymphocytes during their spontaneous proliferation, differentiation and apoptosis in vitro. Leuk. Res. 22:135-143.
Kenyon, S. J., and C. E. Piper. 1977. Cellular basis of persistent lymphocytosis in cattle infected with bovine leukemia virus. Infect. Immun. 16:891-897.
Korz, C., A. Pscherer, A. Benner, D. Mertens, C. Schaffner, E. Leupolt, H. Dohner, S. Stilgenbauer, and P. Lichter. 2002. Evidence for distinct pathomechanisms in B-cell chronic lymphocytic leukemia and mantle cell lymphoma by quantitative expression analysis of cell cycle and apoptosis-associated genes. Blood 99:4554-4561.
Letesson, J. J., A. Van den Broecke, Y. Marbaix-Cleuter, M. Delcommenne, A. Mager, M. Mammerickx, A. Burny, and A. Depelchin. 1991. FACS analysis of bovine leukemia virus (BLV)-infected cell lines with monoclonal antibodies (mAbs) to B cells and to monocytes/macrophages. Vet. Immunol. Immunopathol. 27:207-213.
Matheise, J. P., M. Delcommenne, A. Mager, C. H. Didembourg, and J. J. Letesson. 1992. CD5 and B cells from bovine leukemia virus infected cows are activated cycling cells responsive to interleukin 2. Leukemia 6:304-309.
Meirom, R., S. Moss, J. Brenner, D. Heller, and Z. Trainin. 1997. Levels and role of cytokines in bovine leukemia virus (BLV) infection. Leukemia 11(Suppl. 3):219-220.
Merezak, C., M. Reichert, C. Van Lint, P. Kerkhofs, D. Portetelle, L. Willems, and R. Kettmann. 2002. Inhibition of histone deacetylases induces bovine leukemia virus expression in vitro and in vivo. J. Virol. 76:5034-5042.
Molica, S. 1997. Prognostic value of biological variables in B-cell chronic lymphocytic leukemia. Can we improve upon clinical parameters? Haematologica 82:705-709.
Montserrat, E., F. Bosch, and C. Rozman. 1997. Treatment of B-cell chronic lymphocytic leukaemia: current status and future perspectives. J. Intern. Med. Suppl. 740:63-67.
Nagai, M., M. B. Brennan, J. A. Sakai, C. A. Mora, and S. Jacobson. 2001. CD8(+) T cells are an in vivo reservoir for human T-cell lymphotropic virus type I. Blood 98:1858-1861.
Pyeon, D., K. L. O'Reilly, and G. A. Splitter. 1996. Increased interleukin-10 mRNA expression in tumor-bearing or persistently lymphocytotic animals infected with bovine leukemia virus. J. Virol. 70:5706-5710.
Reed, J. C., S. Kitada, Y. Kim, and J. Byrd. 2002. Modulating apoptosis pathways in low-grade B-cell malignancies with biological response modifiers. Semin. Oncol. 29:10-24.
Rosenwald, A., and L. M. Staudt. 2002. Clinical translation of gene expression profiling in lymphomas and leukemias. Semin. Oncol. 29:258-263.
Rozman, C., and E. Montserrat. 1995. Chronic lymphocytic leukemia. N. Engl. J. Med. 333:1052-1057.
Schattner, E. J. 2002. Apoptosis in lymphocytic leukemias and lymphomas. Cancer Investig. 20:737-748.
Schwartz-Cornil, I., N. Chevallier, C. Belloc, D. Le Rhun, V. Laine, M. Berthelemy, A. Mateo, and D. Levy. 1997. Bovine leukaemia virus-induced lymphocytosis in sheep is associated with reduction of spontaneous B-cell apoptosis. J. Gen. Virol. 78:153-162.
Stephenson, C. F., Z. R. Desai, and J. M. Bridges. 1991. The proliferative activity of B-chronic lymphocytic leukaemia lymphocytes prior to and after stimulation with TPA and PHA. Leuk. Res. 15:1005-1012.
Stone, D. M., L. K. Norton, and W. C. Davis. 2000. Spontaneously proliferating lymphocytes from bovine leukaemia virus-infected, lymphocytotic cattle are not the virus-expressing lymphocytes, as these cells are delayed in G(0)/G(1) of the cell cycle and are spared from apoptosis. J. Gen. Virol. 81:971-981.
Stone, D. M., L. K. Norton, N. S. Magnuson, and W. C. Davis. 1996. Elevated pim-1 and c-myc proto-oncogene induction in B lymphocytes from BLV-infected cows with persistent B lymphocytosis. Leukemia 10:1629-1638.
Trueblood, E. S., W. C. Brown, G. H. Palmer, W. C. Davis, D. M. Stone, and T. F. McElwain. 1998. B-lymphocyte proliferation during bovine leukemia virus-induced persistent lymphocytosis is enhanced by T-lymphocyte-derived interleukin-2. J. Virol. 72:3169-3177.
Ward, J. H. 2001. Autoimmunity in chronic lymphocytic leukemia. Curr. Treat. Options Oncol. 2:253-257.
Wierda, W. G. and S. O'Brien. 2001. Immunotherapy of chronic lymphocytic leukemia. Expert Rev. Anticancer Ther. 1:73-83.
Willems, L., A. Burny, D. Collete, O. Dangoisse, F. Dequiedt, J. S. Gatot, P. Kerkhofs, L. Lefebvre, C. Merezak, T. Peremans, D. Portetelle, J. C. Twizere, and R. Kettmann. 2000. Genetic determinants of bovine leukemia virus pathogenesis. AIDS Res. Hum. Retrovir. 16:1787-1795.
Wolowiec, D., L. Ciszak, A. Kosmaczewska, D. Bocko, R. Teodorowska, I. Frydecka, and K. Kuliczkowski. 2001. Cell cycle regulatory proteins and apoptosis in B-cell chronic lymphocytic leukemia. Haematologica 86:1296-1304.
Yakobson, B., J. Brenner, H. Ungar-Waron, and Z. Trainin. 2000. Cellular immune response cytokine expression during the initial stage of bovine leukemia virus (BLV) infection determines the disease progression to persistent lymphocytosis. Comp. Immunol. Microbiol. Infect. Dis. 23:197-208.
Yoshida, M. 1996. Molecular biology of human T-cell lymphotropic virus-I: recent progress. J. Acquir. Immune. Defic. Syndr. Hum. Retrovirol. 13(Suppl. 1):S63-S68.
